Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93

Showing 26-50 of 93 citing articles:

Applications of Artificial Intelligence in Drug Repurposing
Zhaoman Wan, Xinran Sun, Yi Li, et al.
Advanced Science (2025)
Open Access
Structural landscape of new salts of the antihistamine drug bilastine: implications in physicochemical properties and anticancer activity against skin cancer
Manimurugan Kanagavel, Rajan Marystella Sparjan Samuvel, Vaikundamoorthy Ramalingam, et al.
CrystEngComm (2025)
Closed Access
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Organotin(IV) complexes: Emerging Frontiers in anticancer therapeutics and bioimaging applications
Yang Zi, Fahad A. Alhumaydhi, Waleed Al Abdulmonem, et al.
Coordination Chemistry Reviews (2025) Vol. 534, pp. 216582-216582
Closed Access
Exploiting the Achilles’ heel of cancer through a structure-based drug-repurposing approach and experimental validation of top drugs using the TRAP assay
Divpreet Kaur, Madhu Chopra, Daman Saluja
Molecular Diversity (2025)
Closed Access
Identification of Genomic Instability-Associated LncRNAs as Potential Therapeutic Targets in Lung Adenocarcinoma
Vanessa G. P. Souza, Katya Benard, Greg L. Stewart, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 996-996
Open Access
Drug Repurposing for Inhibiting Triose Phosphate Isomerase of Giardia lamblia (GlTIM) Using a Computational Approach
Adnan Shehzad, Fazal Rabi, N S Shah, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 2, pp. 719-724
Closed Access
Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity
Jie Liu, Guohua Wu, Di Wu, et al.
Lab on a Chip (2025)
Closed Access
Introductory Chapter: Repurposed Drugs – Current State and Future Perspectives
Seçkin Engin
IntechOpen eBooks (2025)
Closed Access
CRISPR/Cas-mediated macromolecular DNA methylation editing: Precision targeting of DNA methyltransferases in cancer therapy
Feng Chena, Lu Chenb
International Journal of Biological Macromolecules (2025), pp. 142401-142401
Closed Access
Molecular mechanisms of berberine’s effects on tumor cells
С. В. Тимофеева, E. Yu. Zlatnik, Лариса Ващенко, et al.
Kazan medical journal (2025)
Open Access
Antibody-drug conjugates and radioconjugates targeting carbonic anhydrase IX and XII in hypoxic tumors: Bench to clinical applications
Sridhar Goud Nerella, Shaik Mahammad Ghouse, Priti Singh, et al.
Bioorganic Chemistry (2025), pp. 108408-108408
Closed Access
Dietary nutrient intake and cancer presence: evidence from a cross-sectional study
Yu Qin, Liu Chen, Zilong Zhao, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Bio-efficacy of Polyethylene Glycol-coated Selenium Nanocomposite Synthesised using Cocos nucifera Haustorium against HepG2 Cell Line
Y Senthamaraikannan, V. Sundaram, Rajeshkumar Shanmugam
International Research Journal of Multidisciplinary Technovation (2025), pp. 165-183
Open Access
Abacavir enhances the efficacy of Doxorubicin via inhibition of histone demethylase KDM5B in breast cancer
Anmi Jose, Pallavi Kulkarni, Naveena A. N. Kumar, et al.
Research Square (Research Square) (2025)
Closed Access
Repurposing serotonergic drugs for gastric cancer: induction of apoptosis in vitro
Fatemeh Abedini, Omolbanin Amjadi, Ghasem Ahangari
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Repositioning antimalarial drugs as anticancer agents: focus on Tafenoquine
Christopher E. Barton, Bailey Blair, Libby Godo, et al.
Experimental Cell Research (2025), pp. 114551-114551
Open Access
Repurposing chlorpromazine for the treatment of triple-negative breast cancer growth and metastasis based on modulation of mitochondria-mediated apoptosis and autophagy/mitophagy
Yamin Pu, Fuyan Xu, Anqi He, et al.
British Journal of Cancer (2025)
Closed Access
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Histone deacetylase inhibitors for leukemia treatment: current status and future directions
Mohammad‐Salar Hosseini, Zohreh Sanaat, Mohammad Amin Akbarzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
MREDTA: A BERT and transformer‐based molecular representation encoder for predicting drug‐target binding affinity
Xu Sun, Juanjuan Huang, Yabo Fang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 19
Open Access | Times Cited: 3
In silico exploration of anti-prostate cancer compounds from differential expressed genes
Basiru Olaitan Ajiboye, Toluwase Hezekiah Fatoki, Olamilekan Ganiu Akinola, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy
Ting Wang, Qianyao Li, Rui Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Epithelial‑derived head and neck squamous tumourigenesis (Review)
Charles Shirima, Coralia Bleoţu, Demetrios�� Spandidos, et al.
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access | Times Cited: 2
A review of the current trends in computational approaches in drug design and metabolism
Russell B. O. Ouma, Silas M. Ngari, Joshua K. Kibet
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2

Scroll to top